Announced Wed, 1 Jul · 17:34 IST
Siddharth Mittal appointed as MD and CEO of Syngene International effective July 1, 2026
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.3%1-day move
₹431.05
prior close
₹434.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.5+0.5+0.5+2.3-0.0-1.9-4.0-3.5-2.3-6.1———
Up moveDown movePending
AI summary
Siddharth Mittal has been appointed as Managing Director and CEO of Syngene International effective July 1, 2026, succeeding Peter Bains whose tenure ended June 30, 2026. Mittal joins from Biocon Limited where he served as MD and CEO, and earlier as CFO for 13 years. He led Biocon's GLP-1 portfolio commercialization globally. Syngene, a global CRDMO with over 8,300 employees, works with around 400 global customers.
Likely market impact
Smooth transition as an experienced executive from Biocon group takes charge. Investors will watch growth recovery and execution.